av/avalo-therapeutics--big.svg

COM:AVALOTX

Avalo Therapeutics, Inc.

  • Stock

USD

Last Close

9.65

22/11 21:00

Market Cap

12.97M

Beta: -

Volume Today

80.44K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
5.50K
-
196.58K
3,474.12%
746.47K
279.73%
565.89K
24.19%
12K
97.88%
20.50K
70.83%
29K
41.46%
10K
65.52%
average payables
1.29M
-
804.62K
37.40%
844.16K
4.91%
1.15M
36.77%
1.37M
18.88%
1.76M
28.38%
2.33M
32.00%
2.97M
27.75%
3.13M
5.18%
1.66M
46.76%
average receivables
66.50K
-
1.91M
2,766.51%
6.15M
222.78%
6.93M
12.71%
4.81M
30.58%
4.59M
4.61%
3.36M
26.85%
1.03M
69.41%
book value per share
-46.25
-
-68.24
47.54%
70.53
203.36%
0.28
99.60%
18.16
6,355.51%
7.22
60.27%
5.88
18.56%
4.42
24.78%
2.66
39.87%
-1.16
143.68%
capex per share
-0.08
-
-0.05
33.37%
-0.11
113.14%
-0.05
56.00%
-0.02
67.93%
-0.19
1,181.09%
-0.07
62.35%
-0.01
84.62%
-0.01
15.39%
-0.01
22.35%
capex to depreciation
-1.46
-
-0.67
53.88%
-0.85
26.16%
-1.30
52.79%
-0.05
95.78%
-0.12
126.03%
-0.07
45.55%
-0.03
49.61%
-0.07
100.60%
-0.57
739.19%
capex to operating cash flow
0.00
-
0.00
50.69%
0.00
56.46%
0.00
21.74%
-0.00
177.84%
0.18
9,784.56%
0.01
92.41%
0.00
88.71%
0.00
3.13%
0.00
122.79%
capex to revenue
-0.03
-
-0.00
97.23%
-0.03
3,572.32%
-0.04
26.04%
-0.01
75.90%
-0.02
123.81%
-0.01
74.86%
cash per share
8.87
-
30.43
243.20%
114.08
274.86%
6.97
93.89%
1.61
76.88%
3.67
127.99%
3.15
14.39%
3.40
8.24%
6.28
84.60%
1.40
77.71%
days of inventory on hand
219.44
-
54.22
75.29%
-13.52
124.93%
3.65
127.00%
9.30
154.86%
2.13
77.15%
days payables outstanding
745.90
-
70.58
90.54%
-1.34K
1,995.19%
3.13K
334.11%
824.74
73.66%
306.33
62.86%
126.78
58.61%
days sales outstanding
42.10
-
48.29
14.69%
171.81
255.81%
283.51
65.02%
238.92
15.73%
324.50
35.82%
38.80
88.04%
35.26
9.14%
debt to assets
0.59
-
0.26
56.16%
0.41
58.88%
0.22
-
0.01
-
0.42
4,162.79%
0.58
40.09%
debt to equity
-0.27
-
0.43
255.14%
11.37
2,574.97%
0.74
-
0.02
-
1.44
8,215.86%
-1.78
223.23%
dividend yield
0.00
-
0.00
-
0.31
-
earnings yield
-0.43
-
-0.53
23.08%
-1.41
163.68%
-2.12
50.68%
0.20
109.51%
-0.36
276.99%
-0.07
80.26%
-0.37
419.44%
-0.48
30.17%
-0.88
84.64%
enterprise value
26.67M
-
25.57M
4.15%
-8.14M
131.85%
5.00M
161.36%
56.44M
1,029.61%
117.05M
107.39%
227.50M
94.36%
157.56M
30.74%
155.44M
1.35%
53.64M
65.49%
-7.42M
113.82%
enterprise value over ebitda
-2.09
-
-1.32
36.64%
0.66
150.02%
-0.31
146.81%
3.93
1,371.97%
18.00
357.42%
-13.10
172.81%
-6.25
52.31%
-1.93
69.14%
-1.43
25.69%
0.27
118.56%
ev to operating cash flow
-2.32
-
-1.65
29.06%
0.80
148.63%
-0.34
142.79%
4.51
1,414.91%
-37.42
930.02%
-11.89
68.23%
-3.89
67.31%
-2.19
43.59%
-2.01
8.55%
0.24
112.05%
ev to sales
4.33
-
2.03
53.17%
6.39
214.74%
33.70
427.71%
23.52
30.21%
28.80
22.42%
2.97
89.68%
-5.27
277.23%
free cash flow per share
-29.84
-
-40.27
34.94%
-54.90
36.32%
-19.85
63.84%
8.15
141.03%
-1.27
115.64%
-5.43
326.00%
-7.31
34.59%
-8.17
11.89%
-2.85
65.08%
free cash flow yield
-0.38
-
-0.52
34.94%
-1.37
164.51%
-1.88
37.66%
0.21
111.28%
-0.03
115.50%
-0.08
155.29%
-0.23
174.79%
-0.40
73.76%
-0.57
41.35%
graham net net
-50.54
-
-69.73
37.97%
67.86
197.32%
-0.45
100.66%
-6.41
1,335.91%
-10.93
70.37%
0.02
100.17%
0.54
2,805.36%
0.12
77.28%
-3.15
2,657.41%
graham number
187.58
-
252.77
34.75%
299.57
18.52%
11.90
96.03%
56.22
372.38%
47.37
15.75%
24.54
48.20%
33.94
38.34%
24.10
29.01%
10.76
55.36%
income quality
0.88
-
0.97
9.78%
0.97
0.24%
0.88
8.68%
1.05
19.21%
0.08
92.60%
1.19
1,424.34%
0.64
46.37%
0.84
31.60%
0.64
23.57%
0.97
51.46%
intangibles to total assets
0
-
0
0
0
0.74
Infinity%
0.68
8.47%
0.47
31.26%
0.37
21.60%
0.18
50.73%
0.43
139.77%
0.50
15.85%
interest coverage
-1.23K
-
14.19
101.16%
13.88
2.18%
34.64
149.57%
-578.36
1,769.56%
48.44
108.38%
34.35
-
-8.98
126.14%
8.16
190.83%
interest debt per share
0.03
-
15.57
56,819.97%
25.71
65.09%
2.57
90.01%
-0.02
100.61%
5.03
32,210.83%
0.08
-
3.56
4,541.32%
2.51
29.56%
inventory turnover
1.66
-
6.73
304.76%
-27
501.04%
100
470.37%
39.24
60.76%
171.70
337.60%
invested capital
-0.27
-
0.43
255.14%
11.37
2,574.97%
0.74
-
0.02
-
1.44
8,215.86%
-1.78
223.23%
market cap
30.10M
-
30.10M
0%
7.46M
75.22%
7.77M
4.21%
58.91M
658.13%
112.32M
90.66%
231.11M
105.76%
176.06M
23.82%
177.19M
0.64%
47.39M
73.25%
net current asset value
-18.79M
-
-26.49M
40.99%
13.05M
149.27%
101K
99.23%
-4.27M
4,330.81%
-27.41M
541.48%
2.61M
109.52%
6.81M
161.00%
4.71M
30.81%
-27.87M
691.26%
-5.29M
81.00%
net debt to ebitda
0.27
-
0.23
12.51%
1.27
441.04%
0.17
86.43%
-0.17
200.34%
0.73
522.13%
0.21
71.43%
0.73
252.84%
0.27
63.20%
-0.17
161.82%
0.27
259.47%
net income per share
-33.81
-
-41.61
23.08%
-56.55
35.90%
-22.38
60.42%
7.74
134.57%
-13.82
278.65%
-4.55
67.05%
-11.59
154.42%
-9.71
16.18%
-4.43
54.38%
operating cash flow per share
-29.77
-
-40.22
35.12%
-54.79
36.23%
-19.80
63.85%
8.16
141.21%
-1.08
113.23%
-5.36
396.08%
-7.29
36.22%
-8.16
11.89%
-2.84
65.15%
payables turnover
0.49
-
5.17
956.76%
-0.27
105.28%
0.12
142.71%
0.44
279.72%
1.19
169.23%
2.88
141.61%
receivables turnover
8.67
-
7.56
12.81%
2.12
71.90%
1.29
39.40%
1.53
18.66%
1.12
26.37%
9.41
736.27%
10.35
10.06%
research and ddevelopement to revenue
8.80
-
0.16
98.21%
0.32
100.84%
1.74
451.97%
4.81
175.74%
11.08
130.66%
1.73
84.35%
9.79
464.44%
return on tangible assets
-2.57
-
-1.30
49.28%
-0.48
62.84%
-2.86
489.47%
1.06
137.23%
-1.77
266.74%
-0.84
52.37%
-2.32
174.73%
-1.28
44.70%
-2.20
71.33%
-3.01
36.83%
revenue per share
1.57
-
18.13
1,057.04%
6.32
65.11%
1.89
70.13%
1.21
36.19%
0.62
48.44%
1.92
208.87%
roe
0.73
-
0.61
16.58%
-0.80
231.48%
-79.57
9,824.64%
0.43
100.54%
-1.92
549.63%
-0.77
59.54%
-2.62
238.23%
-3.65
39.41%
3.82
204.44%
-4.32
213.16%
roic
0.73
-
0.84
14.41%
-0.56
166.96%
-6.42
1,046.37%
0.43
106.66%
-1.08
353.10%
-0.84
22.13%
-1.02
20.58%
-1.44
41.72%
-4.15
187.92%
-3.82
7.97%
sales general and administrative to revenue
6.14
-
0.29
95.35%
0.58
104.03%
1.50
157.45%
2.60
73.36%
4.04
55.55%
1.14
71.74%
shareholders equity per share
-46.25
-
-68.24
47.54%
70.53
203.36%
0.28
99.60%
18.16
6,355.51%
7.22
60.27%
5.88
18.56%
4.42
24.78%
2.66
39.87%
-1.16
143.68%
stock based compensation to revenue
1.47
-
0.04
97.17%
0.13
218.81%
0.38
182.81%
1.01
170.01%
1.51
49.46%
0.42
72.36%
2.47
490.10%
tangible asset value
-17.85M
-
-26.33M
47.54%
13.08M
149.69%
207K
98.42%
-4.10M
2,079.30%
-26.74M
552.72%
4.16M
115.56%
8.57M
105.96%
8.63M
0.78%
-25.32M
393.27%
-3.20M
87.37%
tangible book value per share
-46.25
-
-68.24
47.54%
70.53
203.36%
0.28
99.60%
-2.67
1,049.38%
-9.23
245.56%
1.16
112.62%
1.54
32.43%
0.99
35.52%
-2.69
370.88%
working capital
1.07M
-
7.17M
569.76%
15.77M
120.08%
1.35M
91.43%
-415.07K
130.72%
-4.28M
932.28%
5.56M
229.83%
10.78M
93.78%
41.96M
289.21%
-5.70M
113.58%
3.78M
166.29%

All numbers in USD (except ratios and percentages)